Endocrinology

A systematic review and meta-analysis are diving deeper into the debate over whether metformin should be prescribed to with polycystic ovary syndrome using assisted reproductive technologies, such as in vitro fertilization or intracytoplasmic sperm injection and embryo transfer.

Results of the VESTA trial indicate fezolinetant could one day provide a non-hormonal, oral option for reducing vasomotor menopausal symptoms and improving quality of life in postmenopausal women.

Having 3 or more pregnancies, a shorter reproductive life span, or early age at menopause onset were linked to increased risk of CAD in a recent study.

Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.

An analysis of more than 60k women suggests those with polycystic ovary syndrome were 19% more likely to develop cardiovascular disease.

A practicing endocrinologist and professor of medicine offers insight into the potential for increase in risk of blood clots in certain groups of women if they were to contract COVID-19.

How good are your diagnostic skills? Test them with this month's Visual Dx quiz!

Analysis of CARDIA data indicates smoking was linked to greater volumes of adipose tissue and lower muscle quality, despite having a lower BMI.

A nationwide assessment of data published between 2000-2020 related to outcomes following bariatric surgery is revealing more about its benefits on mortality and incidence of obesity-related disease.

New data suggests bone density measurement follow-ups within 3 years of baseline assessment are unnecessary and a potential misuse of resources.

A new University of Michigan-led study is detailing the effects of national cost-sharing caps on insulin for type 1 diabetics.

Eyes with moderate to severe nonproliferative diabetic retinopathy more often develop eye worsening compared to those with a milder form of the condition.

A total of 115 of 200 examined eyes had some form of diabetic retinopathy in data presented at the ASRS 2020 virtual meeting.

In research presented at ASRS 2020, investigators found 56% of patients with PDR had a DME code, with a sensitivity of 85%.

Jamie Hartmann-Boyce, MA, DPhil, discusses how medical researchers have adapted to the increased pace associated with the COVID-19 era.

The findings of the study highlight the importance of screening eye exams from index diagnosis.

A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.

A look at how primary care patients begin to present with diabetic retinopathy risk.

New research suggests risk of mortality associated with recombinant human growth hormone was linked to underlying diagnosis, not cumulative treatment or mean doses.

A pooled analysis of 6 studies is shedding light on the relationship between early age at menarche and incidence of vasomotor menopausal symptoms.

New study finds 2 different time-restricted feeding approaches were effective for losing weight among obese patients.

A novel polygenic risk score could help identify patients at a low-risk of fracture from osteoporosis or fragility without need for additional screenings.

A new analysis is strengthening the safety profile of abaloparatide (Tymlos) in postmenopausal women to prevent risk of fracture.

Results of an analysis of more than 600 patients suggests increased fasting blood glucose was associated with a 2.3 times greater risk of 28-day mortality in COVID-19 patients.

The microbiome of an infant's first stool can help predict their risk of being overweight later in life, according to a recent study.

Results of an NIH-led study suggests infants exposed to iodine in the NICU were at a greater risk of developing congenital hypothyroidism.

New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.

A systematic review and network meta-analysis is comparing 9 classes of therapies for HbA1c and risk management in patients with low versus increased cardiovascular risk.

Although the investigative team found the overall increase in prevalence did not meet statistical significance, there was a significant increase among young adults, and prevalence remained high for those at least 60 years old.